← Leaderboards
Goutam Chakraborty
Icahn School Of Medicine At Mount Sinai
$793,408
Attributed
$2,380,224
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $857.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,380,224 · 1
By mechanism
R01$2,380,224 · 1
Top collaborators
- Nagavarakishore Pillarsetty5 shared
- Vladimir Ponomarev5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Alison M Goate$50,419,418
- Michael Rendl$16,676,175
- Ping-Ying Pan$4,109,546
- Romina Bevacqua$338,000
- Alec P Pankow$97,512
Others in their field
Other Rising Stars on “Mortality”
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Carolina Porras · Fundacion Inciensa$10,814,023
- Christine W Hockett · Avera Mckennan$8,908,366
- Michael E. Roth · Public Health Institute$8,201,777
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,127,032
Research focus
MortalityResistanceGenesMolecularOrganoidsReportingGene MutationGene RepairKnock-OutMalignant Neoplasm Of ProstateCombined Modality TherapyCancer PatientProstate Cancer ProgressionRadiation TherapyDna RepairDna Sequence AlterationCastrationBrca2 GeneCellsImmunotherapyCancer BiologyLoss Of FunctionAndrogen ReceptorSignal Pathway
Grant awards (5)
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer$722,240
R01 · FY2025 · CA · contact PI
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer$135,585
R01 · FY2025 · CA · contact PI
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer$678,271
R01 · FY2024 · CA · contact PI
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer$114,678
R01 · FY2024 · CA · contact PI
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer$729,450
R01 · FY2023 · CA · contact PI